LMO2 and kidney cancer: In the current study, analysis of the TCGA Pan-cancer dataset revealed that LMO2 expression was elevated in glioblastoma but reduced in most other cancer types, particularly in epithelial-derived tumors such as breast, colon, rectal, lung, and kidney cancer.